此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

儿科照射:神经认知、神经影像学以及记忆和注意力评估 (IPANEMA)

2026年10月30日 更新者:Institut Claudius Regaud

This is a prospective, open-label, multicentric study designed to correlate the dose delivered to the hippocampus with declarative memory deficits 2 years after radiotherapy treatment in a paediatric population who had received brain irradiation between the ages of 4 and 12 for a brain tumour.

In order to meet this objective, several neuropsychological assessments consisting of parental questionnaires and cognitive tests will be carried out during the course of the study, at the following two stages:

  • A 1st assessment at patient inclusion, i.e. 2 years after the end of radiotherapy treatment,
  • And a second assessment 2 years after patient inclusion, i.e. 4 years after the end of radiotherapy treatment.

A retrospective assessment of the patient's neurocognitive level 1 year before the diagnosis of the disease will also be carried out at inclusion, with the parents completing a questionnaire specifically designed for the trial.

In addition, patients who have received their radiotherapy treatment at the IUCT-O will be offered participation in the ancillary imaging study. If the parents and the patient agree, multimodal MRI scans specific to the study (without injection of contrast) will be performed at inclusion and 2 years after inclusion.

Imaging and radiotherapy data will be collected in parallel using the PediaRT software used in current practice (collection of radiotherapy dosimetric data as well as standard MRI examinations pre-operatively, post-operatively, and at the 2-year and 4-year follow-up).

130 patients will be included in this study.

研究概览

研究类型

介入性

注册 (估计的)

130

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • Angers、法国
      • Bordeaux、法国
      • Caen、法国
      • Lille、法国
        • 尚未招聘
        • Centre Oscar Lambret
        • 接触:
      • Lyon、法国
        • 招聘中
        • Centre Léon Bérard
        • 接触:
      • Marseille、法国
        • 招聘中
        • APHM - Hôpital la Timone
        • 接触:
      • Montpellier、法国
      • Paris、法国
      • Rennes、法国
      • Saint-Herblain、法国
      • Strasbourg、法国
        • 招聘中
        • Centre Paul Strauss
        • 接触:
      • Toulouse、法国
      • Vandœuvre-lès-Nancy、法国
      • Villejuif、法国
        • 招聘中
        • Institut Gustave Roussy
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

6年 至 14年 (孩子)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Patient who has received localised brain irradiation or craniospinal irradiation for a brain tumour whose treatment includes first-line radiotherapy.
  2. Patient with one of the following tumour types: ependymomas, medulloblastomas, malignant germ cell tumours, craniopharyngioma, pinealoblastoma.
  3. Patient aged between 4 and 12 years at the time of radiotherapy treatment.
  4. End of irradiation within 2 years (+/-3 months) prior to inclusion.
  5. Patient having been treated by photontherapy or proton therapy.
  6. Sufficient visual, auditory (with authorised hearing aid) and oral or written expression capacity to carry out the neuropsychological tests properly.
  7. Proficiency in the French language by the patient and parent(s).
  8. Patient affiliated to a Social Security scheme in France.
  9. Informed consent signed by the patient/legal parent(s)/guardian(s) in accordance with French law and Good Clinical Practice.

Exclusion Criteria:

  1. Patient presenting with severe ataxia.
  2. Patient with a recurrence of the disease.
  3. Not applicable since protocol version 2. Metastatic patient.
  4. Any contraindication to MRI for patients included in Toulouse (i.e. in particular patients with a pacemaker or cardiac defibrillator, implanted equipment activated by an electrical, magnetic or mechanical system, patients with haemostatic clips on intracerebral aneurysms, patients with orthopaedic implants, claustrophobic patients).
  5. Patients undergoing psychostimulant or psychotropic treatment (in particular methylphenidate, antidepressants).
  6. Any psychological, family, geographical or sociological condition that prevents compliance with medical monitoring and/or the procedures set out in the study protocol.
  7. Patients deprived of their liberty or under legal protection.
  8. Severe posterior fossa syndrome with akinetic mutism.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
其他:入组前 2 年接受一线放射治疗的脑肿瘤患者。

Several neuropsychological assessments were carried out during the study (at inclusion and 2 years after inclusion), consisting of :

  • parental questionnaires (standard questionnaires and questionnaires specifically drawn up for the trial). The aim of these questionnaires will be to assess the patient's neurocognitive level at different times (before and after radiotherapy treatment).
  • patient cognitive tests (½ day face-to-face consultation/assessment with a neuropsychologist specialising in paediatrics, followed by a 30-minute telephone call).

Only for patients having received their radiotherapy treatment at the IUCT-O: a multimodal MRI specific to the study (without injection of contrast product) may be performed at inclusion and 2 years after inclusion.

研究衡量的是什么?

主要结果指标

结果测量
大体时间
陈述性记忆缺陷的定义是儿童记忆量表 (CMS) 的标准分数≤ 5
大体时间:每位患者 24 个月
每位患者 24 个月

次要结果测量

结果测量
措施说明
大体时间
陈述性记忆将使用改编后的 EPIREAL 测试进行评估。
大体时间:每位患者 24 个月
每位患者 24 个月
陈述性记忆将通过自传体记忆问题进行评估。
大体时间:每位患者 24 个月
每位患者 24 个月
程序记忆的缺陷将由概率分类任务的最后 20 次试验(满分 50 次)的分数小于或等于 10/20 来定义。
大体时间:每位患者 24 个月
每位患者 24 个月
程序记忆的缺陷将由小于或等于适应串行反应时间任务(SRTT)零的特定学习分数来定义。
大体时间:每位患者 24 个月
每位患者 24 个月
Working memory deficit will be defined if at least one of the two subtests (Number memory (WISC-V) and Spatial memory (WNV)) shows a deficit.
大体时间:24 months for each patient

For each subtest, a deficit will be defined respectively by a standard score ≤ 5 and a percentile rank ≤ 5.

24 months for each patient

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年10月21日

初级完成 (估计的)

2030年10月1日

研究完成 (估计的)

2030年10月1日

研究注册日期

首次提交

2024年9月5日

首先提交符合 QC 标准的

2024年9月12日

首次发布 (实际的)

2024年9月19日

研究记录更新

最后更新发布 (实际的)

2026年11月3日

上次提交的符合 QC 标准的更新

2026年10月30日

最后验证

2025年11月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅